AKT1 and leukemia: Given that the TIMP1/CD63/PI3K/AKT/p21 axis has been described as a molecular mechanism that promotes leukemia cell proliferation and survival [52], we investigated whether TIMP1 expression could be associated with eribulin resistance, but we detected no association (Figure S4).